Mark your Calendars for Targeting Phage Therapy 2025
The Scientific Committee published the first Agenda of the 8th World Conference on Targeting Phage Therapy, which will be held on June 10-11, 2025, at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany. Read More
Speakers Lineup 2025
Keynote Speech – Phage Therapy 2030: Getting from here to there
Robert T. SchooleyUniversity of California, San Diego, USA
Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare
Christian WillyAcademic Hospital Bundeswehr Berlin, Germany
Complex Phage Communities Control Gut (im)balances and May Hold the Key to Restore Gut Biosis
Dennis Sandris NielsenUniversity of Copenhagen, Denmark
Inhaled Bacteriophage Therapy for Multidrug Resistant Pseudomonas Aeruginosa: Advances & Perspectives
Gail L. StanleyYale University, USA
KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut
Franklin NobregaUniversity of Southampton, United Kingdom
Optimizing the Phage-Bacteria Ratio in Phage Therapy: Metagenomic Insights into Microbial Balance and Dysbiosis
Domenico FrezzaUniversity of Roma Tor Vergata, Italy
Phage Defense Systems: Are they an Obstacle for Phage Therapy?
Stan J.J. BrounsDelft University of Technology, The Netherlands
Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity
Jumpei FujikiRakuno Gakuen University, Japan
Yersinia Phage Stories: Impact on Phage Therapy
Mikael SkurnikUniversity of Helsinki, Finland
Targeting Tumors with Engineered Phages: A New Frontier in Precision Oncology
Alberto DanielliUniversity of Bologna, Italy
Engineering Phages for Cancer Therapy: Insights into Immune Interactions and Targeting in Ex-Vivo and In-Vivo Models
Alena KaltenbrunnerUniversity of Bologna, Italy
Endolysin B as a New Approach & Archetype in M. Tuberculosis Treatment
Loris RizzelloUniversity of Milan, Italy
Ex vivo pig lung as a new Cystic Fibrosis model for the study of Pseudomonas aeruginosa biofilm infection and phage therapy application
Marco CaforaUniversity of Milan, Italy
Translating Phage Therapy into the Clinic: Recent Accomplishments and Next Challenges
Jeremy BarrMonash University, Australia
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Christian KühnHannover Medical School, Germany
Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan
Hidetomo IwanoRakuno Gakuen University, Japan
Bacteriophages Applications in Broiler Farms: Strategies & Perspectives
Sandra Sevilla-NavarroCentro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana, Spain
Phage Therapy in Europe: Legal, Regulatory and Ethic Issues
Barbara BrennerKanzlei BRENNER, Germany
Short Oral Communications 2025
New Insights into Bacteriophage Therapy in Dogs
Eva Maria Kalbhenn, LABOKLIN GmbH & Co. KG, Germany
Biohybrid Composites of Platelet-Rich Fibrin and Gelatin Hydrogel Beads (Nano/Micro) for Targeted Phage Delivery in the Treatment of Infected Wounds
Farzaneh Moghtader, TiPhage, Turkey
Phage-Antibiotic Composite Efficacy on Dual-Species Biofilm
Tea Glonti, Queen Astrid Military Hospital, Belgium
Anti-Quorum Sensing Phages Rescue Galleria mellonella Larvae from Pseudomonas aeruginosa Infection
Kira Céline Koonce, University of Copenhagen, Denmark
Who is Attending
Companies, Hospitals, Clinical Centers, and Industry Organizations
Jafral (Supporter)
Aptar Radolfzell GmbH
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana
ArGe Teknoloji Sanayi ve Ticaret Anonim Şirketi
FAGOFARMA
TiPHAGE
Grachtenhaus-Apotheke e.K.
German Collection of Microorganisms and Cell Cultures GmbH
Kanzlei BRENNER
Komplementäre Tiermedizin GmbH
LABOKLIN GmbH & Co. KG
Laboklin Phage Center
Laboratorios Syva
MB PHARMA
MEDIOS AG
Rime Bioinformatics
Phileo by Lesaffre
Phagos
Poulpharm
Academic Hospital Bundeswehr Berlin
Center de investigación en red – Enfermedades Respiratorias
Centre hospitalier universitaire vaudois
IIS-Fundación Jiménez Díaz and CIBERINFEC-Consorcio Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas
Federal research and clinical center of intensive care medicine and rehabilitology
Hannover Medical School
Shanghai Public Health Clinical Center
Victor Babes University of Medicine and Pharmacy Timisoara
Vivantes Klinik Bavaria Kreischa
Universities and Academic Institutions
Charles University
Charité – Universitätsmedizin Berlin
Comenius University in Bratislava
Delft University of Technology
Institute of Pharmacology and Toxicology, Veterinary Medicine
INSERM
Karadeniz Technical University
Nanyang Technological University
Leibniz Institute DSMZ
Masaryk University
Max Planck Inst Molecular Genetics
Monash University
HMU Health & Medical University Erfurt
Rakuno Gakuen University
Recep Tayyip Erdoğan University
Stockholm University
Tel Aviv University
UCLouvain
Università degli Studi di Milano
University of Bologna
University of California, San Diego
Université de Paris
University of Copenhagen
University of Helsinki
University of Milan
University of Pisa
University of Roma Tor Vergata
University of Southampton
University of Warwick
Vrije Universiteit Brussel
Yale University
Practical Session: How to Produce, Manufacture,
and Bring Phage Products to Market
This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.
Key topics include: Technical & Manufacturing Aspects, Regulatory & Administrative Aspects, Business & Market Strategy.
Phage Therapy 2024: Towards Personalized Phage Therapy
The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.